Functionally, rhPAI-1 administration reduced sweat secretion and serum acetylcholine levels in a pilocarpine-induced hyperhidrosis mouse model, supporting the therapeutic potential of targeting the PAI-1/CHRNA1 pathway in PFH. The gene discussed is CHRNA1; the disease is Hyperhidrosis.